To determine whether treatment of attention-deficit/hyperactivity disorder ( ADHD ) with osmotic-release oral system ( OROS ) methylphenidate promotes abstinence from smoking among smokers with ADHD who have greater severity of ADHD symptoms at baseline or greater improvement in ADHD during treatment .